WHO WE ARE

INEX Innovate is Asia's first
molecular diagnostics company for women

INEX Innovate is constantly innovating to address valuable clinical unmet needs, and so far has launched 5 diagnostics tests, 7 different laboratory workflows, and developed a broad range of IP.

EXPANSION

Strategic expansion into growing markets

DEVELOPMENT

Development of robust
product pipeline

INNOVATION

Commitment to excellence in laboratory practice

OUR FOCUS

Improving women’s health through

innovative diagnostics

Our commitment to
innovation

INEX is dedicated to applying our R&D and proven commercial capabilities to address unmet needs in women’s and fetal health.
We develop solutions to some of the most prevalent women’s health challenges whilst ensuring equity and access to products.
INNOVATION
PROGRESS
SYNERGY
IP
67
PARTNERSHIPS
25
TEAM
43
ONGOING PROJECTS
4
THE DIFFERENCE

We are a research-driven company with focus on developing diagnostics platforms based on hard science. We work to deliver value to the most important stakeholder — the patient.

MAKING STRIDES

Global Footprint

Singapore
USA
China
United Kingdom
Hong Kong
Indonesia
India
Bangladesh
Myanmar
Malaysia
Thailand
INSIGHTS

Latest news

Announcements

iGene Laboratory Pte. Ltd donates 25,000 SARS-CoV-2 PCR Kits to Indonesia to assist the government of the Republic of Indonesia in managing the Covid-19 disease outbreak

Announcements

INEX Innovate is honoured to have won two awards at this week’s IP Week @ SG – the IPOS IP for Innovation Champion and WIPO IP Enterprise Trophy

Announcements

Hong Kong’s South China Morning Post SCMP’s Singapore National Day Special Report featuring INEX Innovate. Chief Executive Kane Black discusses women’s & foetal molecular diagnostics, COVID-19 RT-PCR testing and progress so far.

Announcements

INEX Innovate’s wholly owned subsidiary iGene Laboratory has been awarded the Health Promotion Board tender for the provision of COVID-19 Antigen Rapid Testing and RT-PCR swab testing services.